Skip to main content

Advertisement

Log in

Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma

  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

TGF-β1, SNAI1 and MMP-9 are implicated in tumor invasion and metastasis. The purpose of this study was to examine TGF-β1, SNAI1 and MMP-9 expression in papillary thyroid carcinoma (PTC), and to assess association of TGF-β1, SNAI1 and MMP-9 expression with several clinicopathological indicators of PTC. TGF-β1, SNAI1 and MMP-9 protein expression in 83 PTCs and their matched normal thyroid specimens were analyzed using immunohistochemistry. The mRNA expression levels of TGF-β1, SNAI1 and MMP-9 in 12 fresh PTC specimens with lymph node metastasis (LNM), 12 fresh PTC specimens without LNM and their matched normal thyroid specimens were assessed by real-time RT-PCR. The results showed that the mRNA and protein expression levels of TGF-β1, SNAI1 and MMP-9 were significantly higher in PTCs than in their matched normal thyroid tissues. There were not significant differences in TGF-β1, SNAI1 and MMP-9 protein expression relative to age, gender, tumor size and TNM stage, except for MMP-9 whose protein expression correlated with tumor size. However, high mRNA and protein expression levels of TGF-β1, SNAI1 and MMP-9 were significantly correlated with LNM. Furthermore, TGF-β1, SNAI1 and MMP-9 protein expression were significantly correlated with one another. Concomitant expression of any two or all of the three molecules had stronger correlation with LNM than did each alone. Collectively, the present results indicate that immunohistochemical and real-time RT-PCR evaluation of TGF-β1, SNAI1 and MMP-9 expression in PTC may be useful to predict the risk of LNM in PTC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Anscher MS (2010) Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15:350–359

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bhowmick NA, Ghiassi M, Bakin A et al (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27–36

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Buergy D, Weber T, Maurer GD et al (2009) Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Int J Cancer 125:894–901

    Article  CAS  PubMed  Google Scholar 

  • Davies B, Waxman J, Wasan H et al (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365–5369

    CAS  PubMed  Google Scholar 

  • Frey RS, Mulder KM (1997) Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 57:628–633

    CAS  PubMed  Google Scholar 

  • Hardy RG, Vicente-Duenas C, Gonzalez-Herrero I et al (2007) Snail family transcription factors are implicated in thyroid carcinogenesis. Am J Pathol 171:1037–1046

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885

    Article  PubMed  Google Scholar 

  • Imai T, Horiuchi A, Wang C et al (2003) Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163:1437–1447

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kononen J, Bubendorf L, Kallioniemi A et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    Article  CAS  PubMed  Google Scholar 

  • Lamar JM, Iyer V, DiPersio M (2008) Integrin alpha 3 beta 1 potentiates TGF beta-mediated induction of MMP-9 in immortalized keratinocytes. J Invest Dermatol 128:575–586

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lamouille S, Derynck R (2007) Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178:437–451

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lang BH, Lo CY, Chan WF, Lam KY, Wan KY (2007) Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 245:366–378

    Article  PubMed Central  PubMed  Google Scholar 

  • Li X, Zhang YY, Wang Q, Fu SB (2005) Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells. World J Gastroenterol 11:61–68

    CAS  PubMed  Google Scholar 

  • Lin CY, Tsai PH, Kandaswami CC et al (2011) Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102:815–827

    Article  CAS  PubMed  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408

    Article  CAS  PubMed  Google Scholar 

  • Lu Y, Wu LQ, Li CS, Wang SG, Han B (2008) Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Hepatobiliary Pancreat Dis Int 7:174–178

    PubMed  Google Scholar 

  • Maeta H, Ohgi S, Terada T (2001) Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch 438:121–128

    Article  CAS  PubMed  Google Scholar 

  • Martin TA, Goyal A, Watkins G, Jiang WG (2005) Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12:488–496

    Article  PubMed  Google Scholar 

  • Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15:117–134

    Article  PubMed Central  PubMed  Google Scholar 

  • Moody SE, Perez D, Pan T-c et al (2005) The transcriptional repressor snail promotes mammary tumor recurrence. Cancer Cell 8:197–209

    Article  CAS  PubMed  Google Scholar 

  • Naber HP, Drabsch Y, Snaar-Jagalska BE et al (2013) Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 435:58–63

    Article  CAS  PubMed  Google Scholar 

  • Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155–166

    Article  CAS  PubMed  Google Scholar 

  • Peinado H, Olmeda D, Cano A (2007) Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415–428

    Article  CAS  PubMed  Google Scholar 

  • Poser I, Dominguez D, Garcia de Herreros A, Varnai A, Buettner R, Bosserhoff AK (2001) Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 276:24661–24666

    Article  CAS  PubMed  Google Scholar 

  • Qiao B, Johnson NW, Gao J (2010) Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered bytransforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37:663–668

    CAS  PubMed  Google Scholar 

  • Raffo D, Pontiggia O, Simian M (2011) Role of MMPs in metastatic dissemination: implications for therapeutic advances. Curr Pharm Biotechnol 12:1937–1947

    Article  CAS  PubMed  Google Scholar 

  • Riesco-Eizaguirre G, Rodriguez I, De la Vieja A et al (2009) The BRAF(V600E) oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 69:8317–8325

    Article  CAS  PubMed  Google Scholar 

  • Sier CF, Kubben FJ, Ganesh S et al (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74:413–417

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Somiari SB, Somiari RI, Heckman CM et al (2006) Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119:1403–1411

    Article  CAS  PubMed  Google Scholar 

  • Sun L, Diamond ME, Ottaviano AJ, Joseph MJ, Ananthanarayan V, Munshi HG (2008) Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 6:10–20

    Article  CAS  PubMed  Google Scholar 

  • Takkunen M, Grenman R, Hukkanen M, Korhonen M, Garcia de Herreros A, Virtanen I (2006) Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 54:1263–1275

    Article  CAS  PubMed  Google Scholar 

  • Vasko V, Espinosa AV, Scouten W et al (2007) Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104:2803–2808

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wang ST, Liu JJ, Wang CZ et al (2012) Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma. Oncol Rep 27:1065–1071

    PubMed Central  PubMed  Google Scholar 

  • Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128–139

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang L, Yuan SZ (2002) Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int 1:620–623

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by National Natural Science Foundation of China (No. 81072183), by Chongqing Natural Science Foundation of China (No. CSTC, 2011BA5038), by Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Personnel Ministry (2011), by Scientific Research Foundation of Chongqing Medical University (XBZD201002). The authors thank Dr. Michael Koehler (University of Tennessee, Tennessee) for a critical review of this paper.

Conflict of interest

The authors declare that no competing financial interests exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Min Liu.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 43 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, N., Jiang, R., Yang, JY. et al. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma. J Mol Hist 45, 391–399 (2014). https://doi.org/10.1007/s10735-013-9557-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-013-9557-9

Keywords

Navigation